Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2247 ARTÍCULOS , VIENDO DEL 1801 AL 1815

The Potential of Social Policies in Preventing Dementia: An Ecological Study Using Systematic Review and Meta-Analysis

Bodryzlova Y, Mehrabi F, Bosson A, Maïano C, André C, Bélanger E, Moullec G.

J Aging Soc Policy. 2024 Sep 2;36(5):1004-1025. doi: 10.1080/08959420.2023.2245672. Epub 2023 Aug 25.

Triptolide activates the Nrf2 signaling pathway and inhibits the NF-κB signaling pathway to improve Alzheimer disease

He Z, Botchway BOA, Zhang Y, Liu X.

Metab Brain Dis. 2024 Jan;39(1):173-182. doi: 10.1007/s11011-023-01278-4. Epub 2023 Aug 25.

Dysregulation of mTOR by tau in Alzheimer's disease

Bloom GS, Norambuena A.

Cytoskeleton (Hoboken). 2024 Jan;81(1):30-34. doi: 10.1002/cm.21782. Epub 2023 Aug 28.

Alzheimer's disease phenotype based upon the carrier status of the apolipoprotein E ɛ4 allele

Ji XY, Peng XY, Tang HL, Pan H, Wang WT, Wu J, Chen J, Wei NL.

Brain Pathol. 2024 Jan;34(1):e13208. doi: 10.1111/bpa.13208. Epub 2023 Aug 30.

Endocytosis and Alzheimer's disease

Zadka Ł, Sochocka M, Hachiya N, Chojdak-Łukasiewicz J, Dzięgiel P, Piasecki E, Leszek J.

Geroscience. 2024 Feb;46(1):71-85. doi: 10.1007/s11357-023-00923-1. Epub 2023 Aug 30.

How brain 'cleaners' fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer's disease

Ni J, Xie Z, Quan Z, Meng J, Qing H.

Glia. 2024 Feb;72(2):227-244. doi: 10.1002/glia.24465. Epub 2023 Aug 31.

Alzheimer's Disease-Related Epigenetic Changes: Novel Therapeutic Targets

Paniri A, Hosseini MM, Akhavan-Niaki H.

Mol Neurobiol. 2024 Mar;61(3):1282-1317. doi: 10.1007/s12035-023-03626-y. Epub 2023 Sep 12.

Placebo analgesia and nocebo hyperalgesia in patients with Alzheimer disease and healthy participants

Matthiesen ST, Sieg M, Andersen SS, Amanzio M, Finnerup NB, Jensen TS, Gottrup H, Vase L.

Pain. 2024 Feb 1;165(2):440-449. doi: 10.1097/j.pain.0000000000003035. Epub 2023 Sep 8.

Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease

Bettinetti-Luque M, Trujillo-Estrada L, Garcia-Fuentes E, Andreo-Lopez J, Sanchez-Varo R, Garrido-Sánchez L, Gómez-Mediavilla Á, López MG, Garcia-Caballero M, Gutierrez A, Baglietto-Vargas D.

Br J Pharmacol. 2024 Mar;181(6):840-878. doi: 10.1111/bph.16243. Epub 2023 Oct 3.

Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease

Kron JOJ, Keenan RJ, Hoyer D, Jacobson LH.

Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:359-386. doi: 10.1146/annurev-pharmtox-040323-031929. Epub 2023 Sep 14.

Comparative study of Raman spectroscopy techniques in blood plasma-based clinical diagnostics: A demonstration on Alzheimer's disease

Kralova K, Kral M, Vrtelka O, Setnicka V.

Spectrochim Acta A Mol Biomol Spectrosc. 2024 Jan 5;304:123392. doi: 10.1016/j.saa.2023.123392. Epub 2023 Sep 9.

mTOR signaling and Alzheimer's disease: What we know and where we are?

Davoody S, Asgari Taei A, Khodabakhsh P, Dargahi L.

CNS Neurosci Ther. 2024 Apr;30(4):e14463. doi: 10.1111/cns.14463. Epub 2023 Sep 18.

Stress granule-mediated RNA regulatory mechanism in Alzheimer's disease

Sato K, Takayama KI, Inoue S.

Geriatr Gerontol Int. 2024 Mar;24 Suppl 1:7-14. doi: 10.1111/ggi.14663. Epub 2023 Sep 19.

Artificial light and neurodegeneration: does light pollution impact the development of Alzheimer's disease?

Karska J, Kowalski S, Gładka A, Brzecka A, Sochocka M, Kurpas D, Beszłej JA, Leszek J.

Geroscience. 2024 Feb;46(1):87-97. doi: 10.1007/s11357-023-00932-0. Epub 2023 Sep 21.

NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease

Li L, Jin M, Tan J, Xiao B.

CNS Neurosci Ther. 2024 Apr;30(4):e14476. doi: 10.1111/cns.14476. Epub 2023 Sep 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias